Page 1 of Clinical Trials for AGO Study Group [SPONSOR-COLLABORATORS], 25 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Last Updated: February 24, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Malignant Tumor of Peritoneum
2
Recruiting
Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian Cancer
Last Updated: November 15, 2011
Condition(s): Genital Diseases, Female; Ovarian Diseases; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms
3
Recruiting
Chemo- and Radiotherapy in Epithelial Vulvar Cancer
Last Updated: June 2, 2011
Condition(s): Radio/Chemotherapy in Node Positive Advanced Vulvar Cancer
4
Completed
Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
Last Updated: July 19, 2010
Condition(s): Cancer of the Ovary Treated as 2nd Line Therapy; Muellerian Mixed Tumours; Tumours of the Uterus; Cervical Cancers; Non-Epithelial Ovarian Tumours
5
Completed
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer
Last Updated: November 13, 2006
Condition(s): Ovarian Cancer
6
Active, not recruiting
Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-Line Treatment of Ovarian Cancer
Last Updated: May 6, 2008
Condition(s): Epithelial Ovarian Cancer
7
Completed
Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer
Last Updated: February 11, 2011
Condition(s): Ovarian Cancer
8
Completed
Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response
Last Updated: September 29, 2006
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
9
Completed
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients
Last Updated: November 7, 2006
Condition(s): Ovarian Cancer; Fallopian Tube Neoplasms; Peritoneal Neoplasms
10
Active, not recruiting
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
Last Updated: October 25, 2011
Condition(s): Mesenchymal Tumor; Carcinosarcoma; Leiomyosarcoma
11
Active, not recruiting
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
Last Updated: December 30, 2008
Condition(s): Platinum Refractory Epithelial Ovarian Cancer; Primary Cancer of the Peritoneum; Cancer of the Fallopian Tube
12
Completed
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy
Last Updated: July 19, 2010
Condition(s): Ovarian Cancer; Cancer of the Fallopian Tube; Peritoneal Cancer
13
Terminated
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum
Last Updated: September 16, 2005
Condition(s): Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum; Platinum Sensitve Relapse; Anemia
14
Completed
Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer
Last Updated: August 3, 2006
Condition(s): Ovarian Cancer
15
Recruiting
Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
Last Updated: March 6, 2012
Condition(s): Genital Diseases, Female; Ovarian Diseases; Ovarian Neoplasms; Endometrial Neoplasms
16
Active, not recruiting
Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
Last Updated: June 21, 2011
Condition(s): Ovarian Cancer
17
Active, not recruiting
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
Last Updated: August 17, 2010
Condition(s): Fallopian Tube Cancer; Ovarian Cancer
18
Active, not recruiting
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Last Updated: April 19, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
19
Active, not recruiting
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
Last Updated: July 23, 2008
Condition(s): Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Sarcoma
20
Completed
Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
Last Updated: June 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=AGO+Study+Group

Page 1 of Clinical Trials for AGO Study Group [SPONSOR-COLLABORATORS], 25 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About